Global Polio Vaccine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Polio Vaccine market size was valued at US$ 1448 million in 2025 and is forecast to a readjusted size of US$ 1950 million by 2032 with a CAGR of 4.1% during review period.
Polio vaccine is a preventive biological product used to prevent poliovirus infection and the risk of acute flaccid paralysis caused by poliomyelitis. It mainly includes injectable Inactivated Polio Vaccine, Oral Polio Vaccine, Sabin-strain Inactivated Polio Vaccine, and multivalent combination vaccines containing polio antigen components. By inducing active immunity against polioviruses, these products protect individuals while helping maintain population-level immune barriers, reduce transmission, and prevent importation risks. Based on technology route, IPV emphasizes safety and long-term protection in the post-eradication stage, OPV emphasizes intestinal mucosal immunity, rapid coverage, and transmission interruption, while combination vaccines improve pediatric vaccination convenience and immunization program efficiency. Polio vaccines combine public health necessity, national strategic reserve value, and high technical barriers, making them one of the most important vaccine categories in the global polio eradication agenda.In 2025, global Polio vaccine production reached approximately 785 million units.The average gross profit margin of this product is 70%.
The market opportunities for polio vaccines are driven by the final stage of global polio eradication, continuous upgrading of immunization programs, and rising vaccine safety requirements. As countries optimize the use structure of OPV and IPV, the polio vaccine market is no longer a single low-price public health category. Instead, it has formed a multilayer product system in which IPV strengthens the safety foundation, OPV interrupts transmission, combination vaccines improve vaccination experience, and novel OPV enhances emergency response. China?s current immunization strategy adopts a sequential schedule of IPV and bOPV, showing that policymakers value both the safety of inactivated vaccines and the herd-immunity role of oral vaccines. WHO prequalification of novel oral polio vaccines further strengthens the global emergency supply system. For manufacturers, polio vaccines represent a strategic product platform connected to national immunization programs, international organization procurement, domestic substitution, combination vaccine upgrading, and global public health cooperation.
The industry?s challenges are concentrated in policy transition, quality regulation, biosafety, and supply stability. OPV has strong transmission-interruption advantages, but because it contains live attenuated virus and carries vaccine-derived virus risks, its routine-use space will gradually adjust as global polio eradication progresses. IPV has a stronger safety profile, but its manufacturing process is more complex and cost-intensive, requiring high standards for cell culture, virus purification, inactivation validation, and antigen consistency. Combination vaccines involve even higher barriers, including multi-antigen compatibility, immune interference, adjuvant systems, and clinical validation. Because polio vaccines are administered to children and used in public health systems, regulators impose strict requirements on registration approval, GMP, batch release, cold-chain traceability, and post-marketing surveillance. Companies lacking stable capacity, international certification, and mature quality systems will find it difficult to build long-term advantages in government procurement and global supply systems.
Downstream demand is expanding from basic immunization to sequential vaccination, catch-up vaccination, emergency stockpiling, outbreak control, international aid, and premium combination vaccination. Disease control systems focus on whether product portfolios can balance safety, coverage efficiency, supply stability, and transmission interruption. Vaccination clinics require products with clear dosage forms, stable distribution, convenient operation, and easy parent communication. International organizations and developing-country markets place greater emphasis on accessibility, cold-chain adaptability, and emergency response speed. The self-pay market focuses more on fewer injections and greater convenience delivered by IPV-containing multivalent vaccines. In the future, demand for polio vaccines will no longer be driven only by birth cohorts, but also by global importation risks, immunization strategy adjustments, combination vaccine upgrading, and public health stockpile mechanisms.
This report is a detailed and comprehensive analysis for global Polio Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Polio Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Polio Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Polio Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Polio Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Polio Vaccine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Polio vaccine is a preventive biological product used to prevent poliovirus infection and the risk of acute flaccid paralysis caused by poliomyelitis. It mainly includes injectable Inactivated Polio Vaccine, Oral Polio Vaccine, Sabin-strain Inactivated Polio Vaccine, and multivalent combination vaccines containing polio antigen components. By inducing active immunity against polioviruses, these products protect individuals while helping maintain population-level immune barriers, reduce transmission, and prevent importation risks. Based on technology route, IPV emphasizes safety and long-term protection in the post-eradication stage, OPV emphasizes intestinal mucosal immunity, rapid coverage, and transmission interruption, while combination vaccines improve pediatric vaccination convenience and immunization program efficiency. Polio vaccines combine public health necessity, national strategic reserve value, and high technical barriers, making them one of the most important vaccine categories in the global polio eradication agenda.In 2025, global Polio vaccine production reached approximately 785 million units.The average gross profit margin of this product is 70%.
The market opportunities for polio vaccines are driven by the final stage of global polio eradication, continuous upgrading of immunization programs, and rising vaccine safety requirements. As countries optimize the use structure of OPV and IPV, the polio vaccine market is no longer a single low-price public health category. Instead, it has formed a multilayer product system in which IPV strengthens the safety foundation, OPV interrupts transmission, combination vaccines improve vaccination experience, and novel OPV enhances emergency response. China?s current immunization strategy adopts a sequential schedule of IPV and bOPV, showing that policymakers value both the safety of inactivated vaccines and the herd-immunity role of oral vaccines. WHO prequalification of novel oral polio vaccines further strengthens the global emergency supply system. For manufacturers, polio vaccines represent a strategic product platform connected to national immunization programs, international organization procurement, domestic substitution, combination vaccine upgrading, and global public health cooperation.
The industry?s challenges are concentrated in policy transition, quality regulation, biosafety, and supply stability. OPV has strong transmission-interruption advantages, but because it contains live attenuated virus and carries vaccine-derived virus risks, its routine-use space will gradually adjust as global polio eradication progresses. IPV has a stronger safety profile, but its manufacturing process is more complex and cost-intensive, requiring high standards for cell culture, virus purification, inactivation validation, and antigen consistency. Combination vaccines involve even higher barriers, including multi-antigen compatibility, immune interference, adjuvant systems, and clinical validation. Because polio vaccines are administered to children and used in public health systems, regulators impose strict requirements on registration approval, GMP, batch release, cold-chain traceability, and post-marketing surveillance. Companies lacking stable capacity, international certification, and mature quality systems will find it difficult to build long-term advantages in government procurement and global supply systems.
Downstream demand is expanding from basic immunization to sequential vaccination, catch-up vaccination, emergency stockpiling, outbreak control, international aid, and premium combination vaccination. Disease control systems focus on whether product portfolios can balance safety, coverage efficiency, supply stability, and transmission interruption. Vaccination clinics require products with clear dosage forms, stable distribution, convenient operation, and easy parent communication. International organizations and developing-country markets place greater emphasis on accessibility, cold-chain adaptability, and emergency response speed. The self-pay market focuses more on fewer injections and greater convenience delivered by IPV-containing multivalent vaccines. In the future, demand for polio vaccines will no longer be driven only by birth cohorts, but also by global importation risks, immunization strategy adjustments, combination vaccine upgrading, and public health stockpile mechanisms.
This report is a detailed and comprehensive analysis for global Polio Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Polio Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Polio Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Polio Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Polio Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Polio Vaccine
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Polio Vaccine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Inactivated Polio Vaccine (IPV)
- Oral Polio Vaccine (OPV)
- Monovalent
- Bivalent
- Trivalent
- Oral Drops
- Sugar Pill
- Injection
- Public
- Private
- Sanofi
- GSK
- Bibcol
- Serum Institute (Bilthoven Biologicals)
- Tiantan Biological
- IMBCA
- Panacea Biotec Ltd
- Bio-Med
- Halfkin Bio-Pharmaceuticals
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
- Chapter 1, to describe Polio Vaccine product scope, market overview, market estimation caveats and base year.
- Chapter 2, to profile the top manufacturers of Polio Vaccine, with price, sales quantity, revenue, and global market share of Polio Vaccine from 2021 to 2026.
- Chapter 3, the Polio Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
- Chapter 4, the Polio Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
- Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
- Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Polio Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
- Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
- Chapter 13, the key raw materials and key suppliers, and industry chain of Polio Vaccine.
- Chapter 14 and 15, to describe Polio Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Polio Vaccine Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Inactivated Polio Vaccine (IPV)
1.3.3 Oral Polio Vaccine (OPV)
1.4 Market Analysis by Virus Type
1.4.1 Overview: Global Polio Vaccine Consumption Value by Virus Type: 2021 Versus 2025 Versus 2032
1.4.2 Monovalent
1.4.3 Bivalent
1.4.4 Trivalent
1.5 Market Analysis by Dosage Form
1.5.1 Overview: Global Polio Vaccine Consumption Value by Dosage Form: 2021 Versus 2025 Versus 2032
1.5.2 Oral Drops
1.5.3 Sugar Pill
1.5.4 Injection
1.6 Market Analysis by Application
1.6.1 Overview: Global Polio Vaccine Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Public
1.6.3 Private
1.7 Global Polio Vaccine Market Size & Forecast
1.7.1 Global Polio Vaccine Consumption Value (2021 & 2025 & 2032)
1.7.2 Global Polio Vaccine Sales Quantity (2021-2032)
1.7.3 Global Polio Vaccine Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Polio Vaccine Product and Services
2.1.4 Sanofi Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Sanofi Recent Developments/Updates
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Polio Vaccine Product and Services
2.2.4 GSK Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 GSK Recent Developments/Updates
2.3 Bibcol
2.3.1 Bibcol Details
2.3.2 Bibcol Major Business
2.3.3 Bibcol Polio Vaccine Product and Services
2.3.4 Bibcol Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Bibcol Recent Developments/Updates
2.4 Serum Institute (Bilthoven Biologicals)
2.4.1 Serum Institute (Bilthoven Biologicals) Details
2.4.2 Serum Institute (Bilthoven Biologicals) Major Business
2.4.3 Serum Institute (Bilthoven Biologicals) Polio Vaccine Product and Services
2.4.4 Serum Institute (Bilthoven Biologicals) Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Serum Institute (Bilthoven Biologicals) Recent Developments/Updates
2.5 Tiantan Biological
2.5.1 Tiantan Biological Details
2.5.2 Tiantan Biological Major Business
2.5.3 Tiantan Biological Polio Vaccine Product and Services
2.5.4 Tiantan Biological Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Tiantan Biological Recent Developments/Updates
2.6 IMBCA
2.6.1 IMBCA Details
2.6.2 IMBCA Major Business
2.6.3 IMBCA Polio Vaccine Product and Services
2.6.4 IMBCA Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 IMBCA Recent Developments/Updates
2.7 Panacea Biotec Ltd
2.7.1 Panacea Biotec Ltd Details
2.7.2 Panacea Biotec Ltd Major Business
2.7.3 Panacea Biotec Ltd Polio Vaccine Product and Services
2.7.4 Panacea Biotec Ltd Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Panacea Biotec Ltd Recent Developments/Updates
2.8 Bio-Med
2.8.1 Bio-Med Details
2.8.2 Bio-Med Major Business
2.8.3 Bio-Med Polio Vaccine Product and Services
2.8.4 Bio-Med Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Bio-Med Recent Developments/Updates
2.9 Halfkin Bio-Pharmaceuticals
2.9.1 Halfkin Bio-Pharmaceuticals Details
2.9.2 Halfkin Bio-Pharmaceuticals Major Business
2.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Product and Services
2.9.4 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: POLIO VACCINE BY MANUFACTURER
3.1 Global Polio Vaccine Sales Quantity by Manufacturer (2021-2026)
3.2 Global Polio Vaccine Revenue by Manufacturer (2021-2026)
3.3 Global Polio Vaccine Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Polio Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Polio Vaccine Manufacturer Market Share in 2025
3.4.3 Top 6 Polio Vaccine Manufacturer Market Share in 2025
3.5 Polio Vaccine Market: Overall Company Footprint Analysis
3.5.1 Polio Vaccine Market: Region Footprint
3.5.2 Polio Vaccine Market: Company Product Type Footprint
3.5.3 Polio Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Polio Vaccine Market Size by Region
4.1.1 Global Polio Vaccine Sales Quantity by Region (2021-2032)
4.1.2 Global Polio Vaccine Consumption Value by Region (2021-2032)
4.1.3 Global Polio Vaccine Average Price by Region (2021-2032)
4.2 North America Polio Vaccine Consumption Value (2021-2032)
4.3 Europe Polio Vaccine Consumption Value (2021-2032)
4.4 Asia-Pacific Polio Vaccine Consumption Value (2021-2032)
4.5 South America Polio Vaccine Consumption Value (2021-2032)
4.6 Middle East & Africa Polio Vaccine Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Polio Vaccine Sales Quantity by Type (2021-2032)
5.2 Global Polio Vaccine Consumption Value by Type (2021-2032)
5.3 Global Polio Vaccine Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Polio Vaccine Sales Quantity by Application (2021-2032)
6.2 Global Polio Vaccine Consumption Value by Application (2021-2032)
6.3 Global Polio Vaccine Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Polio Vaccine Sales Quantity by Type (2021-2032)
7.2 North America Polio Vaccine Sales Quantity by Application (2021-2032)
7.3 North America Polio Vaccine Market Size by Country
7.3.1 North America Polio Vaccine Sales Quantity by Country (2021-2032)
7.3.2 North America Polio Vaccine Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Polio Vaccine Sales Quantity by Type (2021-2032)
8.2 Europe Polio Vaccine Sales Quantity by Application (2021-2032)
8.3 Europe Polio Vaccine Market Size by Country
8.3.1 Europe Polio Vaccine Sales Quantity by Country (2021-2032)
8.3.2 Europe Polio Vaccine Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Polio Vaccine Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Polio Vaccine Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Polio Vaccine Market Size by Region
9.3.1 Asia-Pacific Polio Vaccine Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Polio Vaccine Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Polio Vaccine Sales Quantity by Type (2021-2032)
10.2 South America Polio Vaccine Sales Quantity by Application (2021-2032)
10.3 South America Polio Vaccine Market Size by Country
10.3.1 South America Polio Vaccine Sales Quantity by Country (2021-2032)
10.3.2 South America Polio Vaccine Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Polio Vaccine Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Polio Vaccine Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Polio Vaccine Market Size by Country
11.3.1 Middle East & Africa Polio Vaccine Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Polio Vaccine Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Polio Vaccine Market Drivers
12.2 Polio Vaccine Market Restraints
12.3 Polio Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Polio Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Polio Vaccine
13.3 Polio Vaccine Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Polio Vaccine Typical Distributors
14.3 Polio Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Polio Vaccine Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Inactivated Polio Vaccine (IPV)
1.3.3 Oral Polio Vaccine (OPV)
1.4 Market Analysis by Virus Type
1.4.1 Overview: Global Polio Vaccine Consumption Value by Virus Type: 2021 Versus 2025 Versus 2032
1.4.2 Monovalent
1.4.3 Bivalent
1.4.4 Trivalent
1.5 Market Analysis by Dosage Form
1.5.1 Overview: Global Polio Vaccine Consumption Value by Dosage Form: 2021 Versus 2025 Versus 2032
1.5.2 Oral Drops
1.5.3 Sugar Pill
1.5.4 Injection
1.6 Market Analysis by Application
1.6.1 Overview: Global Polio Vaccine Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Public
1.6.3 Private
1.7 Global Polio Vaccine Market Size & Forecast
1.7.1 Global Polio Vaccine Consumption Value (2021 & 2025 & 2032)
1.7.2 Global Polio Vaccine Sales Quantity (2021-2032)
1.7.3 Global Polio Vaccine Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Polio Vaccine Product and Services
2.1.4 Sanofi Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Sanofi Recent Developments/Updates
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Polio Vaccine Product and Services
2.2.4 GSK Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 GSK Recent Developments/Updates
2.3 Bibcol
2.3.1 Bibcol Details
2.3.2 Bibcol Major Business
2.3.3 Bibcol Polio Vaccine Product and Services
2.3.4 Bibcol Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Bibcol Recent Developments/Updates
2.4 Serum Institute (Bilthoven Biologicals)
2.4.1 Serum Institute (Bilthoven Biologicals) Details
2.4.2 Serum Institute (Bilthoven Biologicals) Major Business
2.4.3 Serum Institute (Bilthoven Biologicals) Polio Vaccine Product and Services
2.4.4 Serum Institute (Bilthoven Biologicals) Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Serum Institute (Bilthoven Biologicals) Recent Developments/Updates
2.5 Tiantan Biological
2.5.1 Tiantan Biological Details
2.5.2 Tiantan Biological Major Business
2.5.3 Tiantan Biological Polio Vaccine Product and Services
2.5.4 Tiantan Biological Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Tiantan Biological Recent Developments/Updates
2.6 IMBCA
2.6.1 IMBCA Details
2.6.2 IMBCA Major Business
2.6.3 IMBCA Polio Vaccine Product and Services
2.6.4 IMBCA Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 IMBCA Recent Developments/Updates
2.7 Panacea Biotec Ltd
2.7.1 Panacea Biotec Ltd Details
2.7.2 Panacea Biotec Ltd Major Business
2.7.3 Panacea Biotec Ltd Polio Vaccine Product and Services
2.7.4 Panacea Biotec Ltd Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Panacea Biotec Ltd Recent Developments/Updates
2.8 Bio-Med
2.8.1 Bio-Med Details
2.8.2 Bio-Med Major Business
2.8.3 Bio-Med Polio Vaccine Product and Services
2.8.4 Bio-Med Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Bio-Med Recent Developments/Updates
2.9 Halfkin Bio-Pharmaceuticals
2.9.1 Halfkin Bio-Pharmaceuticals Details
2.9.2 Halfkin Bio-Pharmaceuticals Major Business
2.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Product and Services
2.9.4 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: POLIO VACCINE BY MANUFACTURER
3.1 Global Polio Vaccine Sales Quantity by Manufacturer (2021-2026)
3.2 Global Polio Vaccine Revenue by Manufacturer (2021-2026)
3.3 Global Polio Vaccine Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Polio Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Polio Vaccine Manufacturer Market Share in 2025
3.4.3 Top 6 Polio Vaccine Manufacturer Market Share in 2025
3.5 Polio Vaccine Market: Overall Company Footprint Analysis
3.5.1 Polio Vaccine Market: Region Footprint
3.5.2 Polio Vaccine Market: Company Product Type Footprint
3.5.3 Polio Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Polio Vaccine Market Size by Region
4.1.1 Global Polio Vaccine Sales Quantity by Region (2021-2032)
4.1.2 Global Polio Vaccine Consumption Value by Region (2021-2032)
4.1.3 Global Polio Vaccine Average Price by Region (2021-2032)
4.2 North America Polio Vaccine Consumption Value (2021-2032)
4.3 Europe Polio Vaccine Consumption Value (2021-2032)
4.4 Asia-Pacific Polio Vaccine Consumption Value (2021-2032)
4.5 South America Polio Vaccine Consumption Value (2021-2032)
4.6 Middle East & Africa Polio Vaccine Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Polio Vaccine Sales Quantity by Type (2021-2032)
5.2 Global Polio Vaccine Consumption Value by Type (2021-2032)
5.3 Global Polio Vaccine Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Polio Vaccine Sales Quantity by Application (2021-2032)
6.2 Global Polio Vaccine Consumption Value by Application (2021-2032)
6.3 Global Polio Vaccine Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Polio Vaccine Sales Quantity by Type (2021-2032)
7.2 North America Polio Vaccine Sales Quantity by Application (2021-2032)
7.3 North America Polio Vaccine Market Size by Country
7.3.1 North America Polio Vaccine Sales Quantity by Country (2021-2032)
7.3.2 North America Polio Vaccine Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Polio Vaccine Sales Quantity by Type (2021-2032)
8.2 Europe Polio Vaccine Sales Quantity by Application (2021-2032)
8.3 Europe Polio Vaccine Market Size by Country
8.3.1 Europe Polio Vaccine Sales Quantity by Country (2021-2032)
8.3.2 Europe Polio Vaccine Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Polio Vaccine Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Polio Vaccine Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Polio Vaccine Market Size by Region
9.3.1 Asia-Pacific Polio Vaccine Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Polio Vaccine Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Polio Vaccine Sales Quantity by Type (2021-2032)
10.2 South America Polio Vaccine Sales Quantity by Application (2021-2032)
10.3 South America Polio Vaccine Market Size by Country
10.3.1 South America Polio Vaccine Sales Quantity by Country (2021-2032)
10.3.2 South America Polio Vaccine Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Polio Vaccine Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Polio Vaccine Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Polio Vaccine Market Size by Country
11.3.1 Middle East & Africa Polio Vaccine Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Polio Vaccine Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Polio Vaccine Market Drivers
12.2 Polio Vaccine Market Restraints
12.3 Polio Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Polio Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Polio Vaccine
13.3 Polio Vaccine Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Polio Vaccine Typical Distributors
14.3 Polio Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Polio Vaccine Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Polio Vaccine Consumption Value by Virus Type, (USD Million), 2021 & 2025 & 2032
Table 3. Global Polio Vaccine Consumption Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 4. Global Polio Vaccine Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Sanofi Basic Information, Manufacturing Base and Competitors
Table 6. Sanofi Major Business
Table 7. Sanofi Polio Vaccine Product and Services
Table 8. Sanofi Polio Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Sanofi Recent Developments/Updates
Table 10. GSK Basic Information, Manufacturing Base and Competitors
Table 11. GSK Major Business
Table 12. GSK Polio Vaccine Product and Services
Table 13. GSK Polio Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. GSK Recent Developments/Updates
Table 15. Bibcol Basic Information, Manufacturing Base and Competitors
Table 16. Bibcol Major Business
Table 17. Bibcol Polio Vaccine Product and Services
Table 18. Bibcol Polio Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Bibcol Recent Developments/Updates
Table 20. Serum?Institute?(Bilthoven?Biologicals) Basic Information, Manufacturing Base and Competitors
Table 21. Serum?Institute?(Bilthoven?Biologicals) Major Business
Table 22. Serum?Institute?(Bilthoven?Biologicals) Polio Vaccine Product and Services
Table 23. Serum?Institute?(Bilthoven?Biologicals) Polio Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Serum?Institute?(Bilthoven?Biologicals) Recent Developments/Updates
Table 25. Tiantan Biological Basic Information, Manufacturing Base and Competitors
Table 26. Tiantan Biological Major Business
Table 27. Tiantan Biological Polio Vaccine Product and Services
Table 28. Tiantan Biological Polio Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Tiantan Biological Recent Developments/Updates
Table 30. IMBCA Basic Information, Manufacturing Base and Competitors
Table 31. IMBCA Major Business
Table 32. IMBCA Polio Vaccine Product and Services
Table 33. IMBCA Polio Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. IMBCA Recent Developments/Updates
Table 35. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
Table 36. Panacea Biotec Ltd Major Business
Table 37. Panacea Biotec Ltd Polio Vaccine Product and Services
Table 38. Panacea Biotec Ltd Polio Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. Panacea Biotec Ltd Recent Developments/Updates
Table 40. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 41. Bio-Med Major Business
Table 42. Bio-Med Polio Vaccine Product and Services
Table 43. Bio-Med Polio Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. Bio-Med Recent Developments/Updates
Table 45. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 46. Halfkin Bio-Pharmaceuticals Major Business
Table 47. Halfkin Bio-Pharmaceuticals Polio Vaccine Product and Services
Table 48. Halfkin Bio-Pharmaceuticals Polio Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
Table 50. Global Polio Vaccine Sales Quantity by Manufacturer (2021-2026) & (K Dose)
Table 51. Global Polio Vaccine Revenue by Manufacturer (2021-2026) & (USD Million)
Table 52. Global Polio Vaccine Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 53. Market Position of Manufacturers in Polio Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 54. Head Office and Polio Vaccine Production Site of Key Manufacturer
Table 55. Polio Vaccine Market: Company Product Type Footprint
Table 56. Polio Vaccine Market: Company Product Application Footprint
Table 57. Polio Vaccine New Market Entrants and Barriers to Market Entry
Table 58. Polio Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 59. Global Polio Vaccine Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 60. Global Polio Vaccine Sales Quantity by Region (2021-2026) & (K Dose)
Table 61. Global Polio Vaccine Sales Quantity by Region (2027-2032) & (K Dose)
Table 62. Global Polio Vaccine Consumption Value by Region (2021-2026) & (USD Million)
Table 63. Global Polio Vaccine Consumption Value by Region (2027-2032) & (USD Million)
Table 64. Global Polio Vaccine Average Price by Region (2021-2026) & (US$/Dose)
Table 65. Global Polio Vaccine Average Price by Region (2027-2032) & (US$/Dose)
Table 66. Global Polio Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 67. Global Polio Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 68. Global Polio Vaccine Consumption Value by Type (2021-2026) & (USD Million)
Table 69. Global Polio Vaccine Consumption Value by Type (2027-2032) & (USD Million)
Table 70. Global Polio Vaccine Average Price by Type (2021-2026) & (US$/Dose)
Table 71. Global Polio Vaccine Average Price by Type (2027-2032) & (US$/Dose)
Table 72. Global Polio Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 73. Global Polio Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 74. Global Polio Vaccine Consumption Value by Application (2021-2026) & (USD Million)
Table 75. Global Polio Vaccine Consumption Value by Application (2027-2032) & (USD Million)
Table 76. Global Polio Vaccine Average Price by Application (2021-2026) & (US$/Dose)
Table 77. Global Polio Vaccine Average Price by Application (2027-2032) & (US$/Dose)
Table 78. North America Polio Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 79. North America Polio Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 80. North America Polio Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 81. North America Polio Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 82. North America Polio Vaccine Sales Quantity by Country (2021-2026) & (K Dose)
Table 83. North America Polio Vaccine Sales Quantity by Country (2027-2032) & (K Dose)
Table 84. North America Polio Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 85. North America Polio Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 86. Europe Polio Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 87. Europe Polio Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 88. Europe Polio Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 89. Europe Polio Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 90. Europe Polio Vaccine Sales Quantity by Country (2021-2026) & (K Dose)
Table 91. Europe Polio Vaccine Sales Quantity by Country (2027-2032) & (K Dose)
Table 92. Europe Polio Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 93. Europe Polio Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 94. Asia-Pacific Polio Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 95. Asia-Pacific Polio Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 96. Asia-Pacific Polio Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 97. Asia-Pacific Polio Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 98. Asia-Pacific Polio Vaccine Sales Quantity by Region (2021-2026) & (K Dose)
Table 99. Asia-Pacific Polio Vaccine Sales Quantity by Region (2027-2032) & (K Dose)
Table 100. Asia-Pacific Polio Vaccine Consumption Value by Region (2021-2026) & (USD Million)
Table 101. Asia-Pacific Polio Vaccine Consumption Value by Region (2027-2032) & (USD Million)
Table 102. South America Polio Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 103. South America Polio Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 104. South America Polio Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 105. South America Polio Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 106. South America Polio Vaccine Sales Quantity by Country (2021-2026) & (K Dose)
Table 107. South America Polio Vaccine Sales Quantity by Country (2027-2032) & (K Dose)
Table 108. South America Polio Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 109. South America Polio Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 110. Middle East & Africa Polio Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 111. Middle East & Africa Polio Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 112. Middle East & Africa Polio Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 113. Middle East & Africa Polio Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 114. Middle East & Africa Polio Vaccine Sales Quantity by Country (2021-2026) & (K Dose)
Table 115. Middle East & Africa Polio Vaccine Sales Quantity by Country (2027-2032) & (K Dose)
Table 116. Middle East & Africa Polio Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 117. Middle East & Africa Polio Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 118. Polio Vaccine Raw Material
Table 119. Key Manufacturers of Polio Vaccine Raw Materials
Table 120. Polio Vaccine Typical Distributors
Table 121. Polio Vaccine Typical Customers
Table 1. Global Polio Vaccine Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Polio Vaccine Consumption Value by Virus Type, (USD Million), 2021 & 2025 & 2032
Table 3. Global Polio Vaccine Consumption Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 4. Global Polio Vaccine Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Sanofi Basic Information, Manufacturing Base and Competitors
Table 6. Sanofi Major Business
Table 7. Sanofi Polio Vaccine Product and Services
Table 8. Sanofi Polio Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Sanofi Recent Developments/Updates
Table 10. GSK Basic Information, Manufacturing Base and Competitors
Table 11. GSK Major Business
Table 12. GSK Polio Vaccine Product and Services
Table 13. GSK Polio Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. GSK Recent Developments/Updates
Table 15. Bibcol Basic Information, Manufacturing Base and Competitors
Table 16. Bibcol Major Business
Table 17. Bibcol Polio Vaccine Product and Services
Table 18. Bibcol Polio Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Bibcol Recent Developments/Updates
Table 20. Serum?Institute?(Bilthoven?Biologicals) Basic Information, Manufacturing Base and Competitors
Table 21. Serum?Institute?(Bilthoven?Biologicals) Major Business
Table 22. Serum?Institute?(Bilthoven?Biologicals) Polio Vaccine Product and Services
Table 23. Serum?Institute?(Bilthoven?Biologicals) Polio Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Serum?Institute?(Bilthoven?Biologicals) Recent Developments/Updates
Table 25. Tiantan Biological Basic Information, Manufacturing Base and Competitors
Table 26. Tiantan Biological Major Business
Table 27. Tiantan Biological Polio Vaccine Product and Services
Table 28. Tiantan Biological Polio Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Tiantan Biological Recent Developments/Updates
Table 30. IMBCA Basic Information, Manufacturing Base and Competitors
Table 31. IMBCA Major Business
Table 32. IMBCA Polio Vaccine Product and Services
Table 33. IMBCA Polio Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. IMBCA Recent Developments/Updates
Table 35. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
Table 36. Panacea Biotec Ltd Major Business
Table 37. Panacea Biotec Ltd Polio Vaccine Product and Services
Table 38. Panacea Biotec Ltd Polio Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. Panacea Biotec Ltd Recent Developments/Updates
Table 40. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 41. Bio-Med Major Business
Table 42. Bio-Med Polio Vaccine Product and Services
Table 43. Bio-Med Polio Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. Bio-Med Recent Developments/Updates
Table 45. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 46. Halfkin Bio-Pharmaceuticals Major Business
Table 47. Halfkin Bio-Pharmaceuticals Polio Vaccine Product and Services
Table 48. Halfkin Bio-Pharmaceuticals Polio Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
Table 50. Global Polio Vaccine Sales Quantity by Manufacturer (2021-2026) & (K Dose)
Table 51. Global Polio Vaccine Revenue by Manufacturer (2021-2026) & (USD Million)
Table 52. Global Polio Vaccine Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 53. Market Position of Manufacturers in Polio Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 54. Head Office and Polio Vaccine Production Site of Key Manufacturer
Table 55. Polio Vaccine Market: Company Product Type Footprint
Table 56. Polio Vaccine Market: Company Product Application Footprint
Table 57. Polio Vaccine New Market Entrants and Barriers to Market Entry
Table 58. Polio Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 59. Global Polio Vaccine Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 60. Global Polio Vaccine Sales Quantity by Region (2021-2026) & (K Dose)
Table 61. Global Polio Vaccine Sales Quantity by Region (2027-2032) & (K Dose)
Table 62. Global Polio Vaccine Consumption Value by Region (2021-2026) & (USD Million)
Table 63. Global Polio Vaccine Consumption Value by Region (2027-2032) & (USD Million)
Table 64. Global Polio Vaccine Average Price by Region (2021-2026) & (US$/Dose)
Table 65. Global Polio Vaccine Average Price by Region (2027-2032) & (US$/Dose)
Table 66. Global Polio Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 67. Global Polio Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 68. Global Polio Vaccine Consumption Value by Type (2021-2026) & (USD Million)
Table 69. Global Polio Vaccine Consumption Value by Type (2027-2032) & (USD Million)
Table 70. Global Polio Vaccine Average Price by Type (2021-2026) & (US$/Dose)
Table 71. Global Polio Vaccine Average Price by Type (2027-2032) & (US$/Dose)
Table 72. Global Polio Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 73. Global Polio Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 74. Global Polio Vaccine Consumption Value by Application (2021-2026) & (USD Million)
Table 75. Global Polio Vaccine Consumption Value by Application (2027-2032) & (USD Million)
Table 76. Global Polio Vaccine Average Price by Application (2021-2026) & (US$/Dose)
Table 77. Global Polio Vaccine Average Price by Application (2027-2032) & (US$/Dose)
Table 78. North America Polio Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 79. North America Polio Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 80. North America Polio Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 81. North America Polio Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 82. North America Polio Vaccine Sales Quantity by Country (2021-2026) & (K Dose)
Table 83. North America Polio Vaccine Sales Quantity by Country (2027-2032) & (K Dose)
Table 84. North America Polio Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 85. North America Polio Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 86. Europe Polio Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 87. Europe Polio Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 88. Europe Polio Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 89. Europe Polio Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 90. Europe Polio Vaccine Sales Quantity by Country (2021-2026) & (K Dose)
Table 91. Europe Polio Vaccine Sales Quantity by Country (2027-2032) & (K Dose)
Table 92. Europe Polio Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 93. Europe Polio Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 94. Asia-Pacific Polio Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 95. Asia-Pacific Polio Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 96. Asia-Pacific Polio Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 97. Asia-Pacific Polio Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 98. Asia-Pacific Polio Vaccine Sales Quantity by Region (2021-2026) & (K Dose)
Table 99. Asia-Pacific Polio Vaccine Sales Quantity by Region (2027-2032) & (K Dose)
Table 100. Asia-Pacific Polio Vaccine Consumption Value by Region (2021-2026) & (USD Million)
Table 101. Asia-Pacific Polio Vaccine Consumption Value by Region (2027-2032) & (USD Million)
Table 102. South America Polio Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 103. South America Polio Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 104. South America Polio Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 105. South America Polio Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 106. South America Polio Vaccine Sales Quantity by Country (2021-2026) & (K Dose)
Table 107. South America Polio Vaccine Sales Quantity by Country (2027-2032) & (K Dose)
Table 108. South America Polio Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 109. South America Polio Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 110. Middle East & Africa Polio Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 111. Middle East & Africa Polio Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 112. Middle East & Africa Polio Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 113. Middle East & Africa Polio Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 114. Middle East & Africa Polio Vaccine Sales Quantity by Country (2021-2026) & (K Dose)
Table 115. Middle East & Africa Polio Vaccine Sales Quantity by Country (2027-2032) & (K Dose)
Table 116. Middle East & Africa Polio Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 117. Middle East & Africa Polio Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 118. Polio Vaccine Raw Material
Table 119. Key Manufacturers of Polio Vaccine Raw Materials
Table 120. Polio Vaccine Typical Distributors
Table 121. Polio Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Polio Vaccine Picture
Figure 2. Global Polio Vaccine Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Polio Vaccine Revenue Market Share by Type in 2025
Figure 4. Inactivated Polio Vaccine (IPV) Examples
Figure 5. Oral Polio Vaccine (OPV) Examples
Figure 6. Global Polio Vaccine Revenue by Virus Type, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Polio Vaccine Revenue Market Share by Virus Type in 2025
Figure 8. Monovalent Examples
Figure 9. Bivalent Examples
Figure 10. Trivalent Examples
Figure 11. Global Polio Vaccine Revenue by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 12. Global Polio Vaccine Revenue Market Share by Dosage Form in 2025
Figure 13. Oral Drops Examples
Figure 14. Sugar Pill Examples
Figure 15. Injection Examples
Figure 16. Global Polio Vaccine Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 17. Global Polio Vaccine Revenue Market Share by Application in 2025
Figure 18. Public Examples
Figure 19. Private Examples
Figure 20. Global Polio Vaccine Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 21. Global Polio Vaccine Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 22. Global Polio Vaccine Sales Quantity (2021-2032) & (K Dose)
Figure 23. Global Polio Vaccine Price (2021-2032) & (US$/Dose)
Figure 24. Global Polio Vaccine Sales Quantity Market Share by Manufacturer in 2025
Figure 25. Global Polio Vaccine Revenue Market Share by Manufacturer in 2025
Figure 26. Producer Shipments of Polio Vaccine by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 27. Top 3 Polio Vaccine Manufacturer (Revenue) Market Share in 2025
Figure 28. Top 6 Polio Vaccine Manufacturer (Revenue) Market Share in 2025
Figure 29. Global Polio Vaccine Sales Quantity Market Share by Region (2021-2032)
Figure 30. Global Polio Vaccine Consumption Value Market Share by Region (2021-2032)
Figure 31. North America Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 32. Europe Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 33. Asia-Pacific Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 34. South America Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 35. Middle East & Africa Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 36. Global Polio Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 37. Global Polio Vaccine Consumption Value Market Share by Type (2021-2032)
Figure 38. Global Polio Vaccine Average Price by Type (2021-2032) & (US$/Dose)
Figure 39. Global Polio Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 40. Global Polio Vaccine Revenue Market Share by Application (2021-2032)
Figure 41. Global Polio Vaccine Average Price by Application (2021-2032) & (US$/Dose)
Figure 42. North America Polio Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 43. North America Polio Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 44. North America Polio Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 45. North America Polio Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 46. United States Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 47. Canada Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 48. Mexico Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 49. Europe Polio Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 50. Europe Polio Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 51. Europe Polio Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 52. Europe Polio Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 53. Germany Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 54. France Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 55. United Kingdom Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 56. Russia Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 57. Italy Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 58. Asia-Pacific Polio Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 59. Asia-Pacific Polio Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 60. Asia-Pacific Polio Vaccine Sales Quantity Market Share by Region (2021-2032)
Figure 61. Asia-Pacific Polio Vaccine Consumption Value Market Share by Region (2021-2032)
Figure 62. China Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 63. Japan Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 64. South Korea Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 65. India Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 66. Southeast Asia Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 67. Australia Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 68. South America Polio Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 69. South America Polio Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 70. South America Polio Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 71. South America Polio Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 72. Brazil Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 73. Argentina Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 74. Middle East & Africa Polio Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 75. Middle East & Africa Polio Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 76. Middle East & Africa Polio Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 77. Middle East & Africa Polio Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 78. Turkey Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 79. Egypt Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 80. Saudi Arabia Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 81. South Africa Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 82. Polio Vaccine Market Drivers
Figure 83. Polio Vaccine Market Restraints
Figure 84. Polio Vaccine Market Trends
Figure 85. Porters Five Forces Analysis
Figure 86. Manufacturing Cost Structure Analysis of Polio Vaccine in 2025
Figure 87. Manufacturing Process Analysis of Polio Vaccine
Figure 88. Polio Vaccine Industrial Chain
Figure 89. Sales Channel: Direct to End-User vs Distributors
Figure 90. Direct Channel Pros & Cons
Figure 91. Indirect Channel Pros & Cons
Figure 92. Methodology
Figure 93. Research Process and Data Source
Figure 1. Polio Vaccine Picture
Figure 2. Global Polio Vaccine Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Polio Vaccine Revenue Market Share by Type in 2025
Figure 4. Inactivated Polio Vaccine (IPV) Examples
Figure 5. Oral Polio Vaccine (OPV) Examples
Figure 6. Global Polio Vaccine Revenue by Virus Type, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Polio Vaccine Revenue Market Share by Virus Type in 2025
Figure 8. Monovalent Examples
Figure 9. Bivalent Examples
Figure 10. Trivalent Examples
Figure 11. Global Polio Vaccine Revenue by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 12. Global Polio Vaccine Revenue Market Share by Dosage Form in 2025
Figure 13. Oral Drops Examples
Figure 14. Sugar Pill Examples
Figure 15. Injection Examples
Figure 16. Global Polio Vaccine Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 17. Global Polio Vaccine Revenue Market Share by Application in 2025
Figure 18. Public Examples
Figure 19. Private Examples
Figure 20. Global Polio Vaccine Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 21. Global Polio Vaccine Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 22. Global Polio Vaccine Sales Quantity (2021-2032) & (K Dose)
Figure 23. Global Polio Vaccine Price (2021-2032) & (US$/Dose)
Figure 24. Global Polio Vaccine Sales Quantity Market Share by Manufacturer in 2025
Figure 25. Global Polio Vaccine Revenue Market Share by Manufacturer in 2025
Figure 26. Producer Shipments of Polio Vaccine by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 27. Top 3 Polio Vaccine Manufacturer (Revenue) Market Share in 2025
Figure 28. Top 6 Polio Vaccine Manufacturer (Revenue) Market Share in 2025
Figure 29. Global Polio Vaccine Sales Quantity Market Share by Region (2021-2032)
Figure 30. Global Polio Vaccine Consumption Value Market Share by Region (2021-2032)
Figure 31. North America Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 32. Europe Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 33. Asia-Pacific Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 34. South America Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 35. Middle East & Africa Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 36. Global Polio Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 37. Global Polio Vaccine Consumption Value Market Share by Type (2021-2032)
Figure 38. Global Polio Vaccine Average Price by Type (2021-2032) & (US$/Dose)
Figure 39. Global Polio Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 40. Global Polio Vaccine Revenue Market Share by Application (2021-2032)
Figure 41. Global Polio Vaccine Average Price by Application (2021-2032) & (US$/Dose)
Figure 42. North America Polio Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 43. North America Polio Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 44. North America Polio Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 45. North America Polio Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 46. United States Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 47. Canada Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 48. Mexico Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 49. Europe Polio Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 50. Europe Polio Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 51. Europe Polio Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 52. Europe Polio Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 53. Germany Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 54. France Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 55. United Kingdom Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 56. Russia Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 57. Italy Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 58. Asia-Pacific Polio Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 59. Asia-Pacific Polio Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 60. Asia-Pacific Polio Vaccine Sales Quantity Market Share by Region (2021-2032)
Figure 61. Asia-Pacific Polio Vaccine Consumption Value Market Share by Region (2021-2032)
Figure 62. China Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 63. Japan Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 64. South Korea Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 65. India Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 66. Southeast Asia Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 67. Australia Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 68. South America Polio Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 69. South America Polio Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 70. South America Polio Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 71. South America Polio Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 72. Brazil Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 73. Argentina Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 74. Middle East & Africa Polio Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 75. Middle East & Africa Polio Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 76. Middle East & Africa Polio Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 77. Middle East & Africa Polio Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 78. Turkey Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 79. Egypt Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 80. Saudi Arabia Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 81. South Africa Polio Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 82. Polio Vaccine Market Drivers
Figure 83. Polio Vaccine Market Restraints
Figure 84. Polio Vaccine Market Trends
Figure 85. Porters Five Forces Analysis
Figure 86. Manufacturing Cost Structure Analysis of Polio Vaccine in 2025
Figure 87. Manufacturing Process Analysis of Polio Vaccine
Figure 88. Polio Vaccine Industrial Chain
Figure 89. Sales Channel: Direct to End-User vs Distributors
Figure 90. Direct Channel Pros & Cons
Figure 91. Indirect Channel Pros & Cons
Figure 92. Methodology
Figure 93. Research Process and Data Source
